Biotechnology
Israeli companies specializing in biotechnology
Biotechnology firms research and develop new medical therapies or agricultural processes. Clinical trial outcomes and regulatory decisions routinely drive extreme price action and liquidity across this industry. Currently, Pluri Inc. ranks as the top gainer, and Kamada Ltd sees maximum volume. The technical and fundamental metrics provided below help quantify these sudden shifts.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 KMDAKamada Ltd | 1.29 B ILS | 2,234 ILA | +3.57% | 109.34 K | 0.97 | 18.69 | 1.20 ILS | −0.66% | 5.74% | Health technology | Strong buy |
 LCTXLineage Cell Therapeutics, Inc. | 823.36 M ILS | 300.7 ILA | +0.23% | 3.4 K | 0.11 | — | −0.55 ILS | +11.12% | 0.00% | Health technology | Strong buy |
 CGENCompugen Ltd. | 607.81 M ILS | 585.0 ILA | −2.94% | 38.66 K | 1.31 | 5.31 | 1.10 ILS | — | 0.00% | Health technology | Strong buy |
 MTLFMatricelf Ltd. | 85.26 M ILS | 240.7 ILA | −0.62% | 2.81 K | 0.06 | — | −1.19 ILS | −7.83% | 0.00% | Health technology | No rating |
 PLURPluri Inc. | 49.03 M ILS | 393.2 ILA | +10.89% | 12.24 K | 0.57 | — | −7.30 ILS | +38.50% | 0.00% | Health technology | No rating |
 IBISIBI SILVER CASTLE LTD | 44.67 M ILS | 2,447 ILA | −0.16% | 1 | 0.00 | — | −15.24 ILS | +46.88% | 0.00% | Health technology | No rating |
 EVGNEvogene Ltd | 20.36 M ILS | 94.3 ILA | −1.77% | 82.65 K | 1.46 | — | −2.72 ILS | +64.30% | 0.00% | Health technology | Strong buy |
 NRGNNRGENE TECHNOLOGIES LTD | 9.24 M ILS | 65.0 ILA | −6.20% | 7.4 K | 0.71 | — | −0.37 ILS | +60.19% | 0.00% | Health technology | No rating |